EUVIMEDEUVIMED entdecken
Crossref

Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease

Xiaohong Jiang, Jintao Zheng iD, Jiacheng Yu, Rui Chen, Minchao Lai, Zheng Liang, Runzhi Zhou, Weilai Fu, Haoyang Yan, Hong Du iD, Ester Segal, Cheng Jiang iD und 3 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.74326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Xiaohong Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biotechnology and Food Engineering, Guangdong Technion-Israel Institute of Technology (GTIIT), Shantou, China. Hauptthemen laut MEDLINE: Parkinson Disease, Membrane Glycoproteins, Biosensing Techniques. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Overseas Program, Guangdong Provincial and Municipal Joint Youth Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early blood‐based diagnosis of Parkinson's disease (PD) remains challenging owing to the lack of reliable composite biomarkers and rapid, sensitive, and cost‐effective detection platforms. Here, we report a bioelectronic sensor based on an organic electrochemical transistor (OECT) driven by a laser‐induced graphene (LIG) array. By integrating an alternating‐current (AC)‐mediated LIG rapid incubation system (LRIS), the platform enables multiplexed protein profiling directly from clinical samples within approximately 6 min, with attomolar‐level detection limits. We identify the glycoprotein non‐metastatic melanoma protein B (GPNMB)/granulin (GRN) ratio as a sensitive composite biomarker of neuroinflammatory dysregulation, showing pronounced alterations at early disease stages and complementing α‐synuclein for PD assessment. In PD mouse models spanning mild to severe stages ( n = 32), this ratio correlated with disease progression and enabled the detection of mild neuronal loss. Clinical validation in healthy individuals and patients with PD or prodromal PD ( n = 54) showed that the GPNMB/GRN ratio distinguished patients with PD from healthy controls with 80% sensitivity, 90% specificity, and 85% accuracy. Incorporating α‐synuclein further improved diagnostic accuracy. This biomarker–platform strategy provides a rapid, ultrasensitive, and scalable framework for blood‐based PD screening and early risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMembrane GlycoproteinsBiosensing TechniquesHumansAnimalsEarly DiagnosisGraphiteBiomarkersMiceElectrochemical TechniquesLasersTransistors, Electronic

Stichwörter der Autor:innen

GPNMB/GRN ratioParkinson's diseaselaser‐induced graphenemultiplexed biosensingorganic electrochemical transistorpoint‐of‐care diagnostics

Substanzen

Membrane GlycoproteinsGPNMB protein, humanGraphiteBiomarkers

Autor:innen und Institutionen

  • Faculty of Biotechnology and Food Engineering, Guangdong Technion-Israel Institute of Technology (GTIIT), Shantou, China.
  • Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology (IIT), Haifa, Israel.
  • Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
  • Department of Neurology, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Department of Biology & Guangdong Provincial Key Laboratory of Marine Biotechnology, College of Science, Shantou University, Shantou, Guangdong, China.
  • School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.

ORCID-Profile: Jintao Zheng, Hong Du, Cheng Jiang, Sahika Inal, Jiacan Su, Keying Guo

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Overseas Program
  • Guangdong Provincial and Municipal Joint Youth Fund Project
  • Guangdong Provincial Key Platform and Science Project
  • GTIIT Startup
  • Technion-GTIIT Joint Seeds
  • GTIIT Mingsheng Energy Technology Research Fund
  • Shenzhen Peacock Team

Zitieren

APA

Jiang, X., Zheng, J., Yu, J., Chen, R., Lai, M., Liang, Z., Zhou, R., Fu, W., Yan, H., Du, H., Segal, E., Jiang, C., Inal, S., Su, J., & Guo, K. (2026). Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease. Advanced Materials. https://doi.org/10.1002/adma.74326

Vancouver

Jiang X, Zheng J, Yu J, Chen R, Lai M, Liang Z, et al. Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease. Advanced Materials. 2026. doi:10.1002/adma.74326

BibTeX
@article{Jiang2026,
  author = {Jiang, Xiaohong and Zheng, Jintao and Yu, Jiacheng and Chen, Rui and Lai, Minchao and Liang, Zheng and Zhou, Runzhi and Fu, Weilai and Yan, Haoyang and Du, Hong and Segal, Ester and Jiang, Cheng and Inal, Sahika and Su, Jiacan and Guo, Keying},
  title = {Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.74326}
}
Kostenlos starten →